Mitchell Levine

2020

In 2020, Mitchell Levine earned a total compensation of $1.1M as Chief Financial Officer at Oncocyte Corp, a 9% decrease compared to previous year.

Compensation breakdown

Bonus$131,670
Change in Pension Value and Nonqualified Deferred Compensation Earnings$721
Option Awards$504,431
Salary$361,999
Stock Awards$44,800
Other$14,839
Total$1,058,460

Levine received $504.4K in option awards, accounting for 48% of the total pay in 2020.

Levine also received $131.7K in bonus, $721 of change in pension value and nonqualified deferred compensation earnings, $362K in salary, $44.8K in stock awards and $14.8K in other compensation.

Rankings

In 2020, Mitchell Levine's compensation ranked 8,388th out of 13,090 executives tracked by ExecPay. In other words, Levine earned more than 35.9% of executives.

ClassificationRankingPercentile
All
8,388
out of 13,090
36th
Division
Manufacturing
3,565
out of 5,618
37th
Major group
Chemicals And Allied Products
1,444
out of 2,251
36th
Industry group
Drugs
1,256
out of 1,951
36th
Industry
In Vitro and In Vivo Diagnostic Substances
28
out of 60
53rd
Source: SEC filing on May 21, 2021.

Levine's colleagues

We found three more compensation records of executives who worked with Mitchell Levine at Oncocyte Corp in 2020.

2020

Albert Parker

Oncocyte Corp

Chief Operating Officer

2020

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

2020

Padma Sundar

Oncocyte Corp

Senior Vice President, Marketing and Market Access

News

You may also like